In 1989, McGill University researcher Dr. Bernard Belleau developed the antiviral drug 3TC (Lamivudine), which became a critical…
On Jul. 23, 1986, the Recombinant hepatitis B vaccine (Recombivax HB by Merck) was licensed. Using recombinant DNA…
In May 1986, the vaccine Recombivax HB, which protects against hepatitis B infection, was approved for marketing in…
In 1986, while teaching a graduate course at the University of Alberta, Dr. Tyrrell found clues that might…
On Sept. 1, 1984, with the enactment of P.L. 98-369 by the U.S. Congress, coverage under Part B…
In 1982, the first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were…
In 1981, the U.S. Food and Drug Administration (FDA) approved a plasma-derived hepatitis B vaccine for human use….
In 1976, Baruch Samuel Blumberg from the Institute for Cancer Research in Philadelphia was awarded the Nobel Prize…
In 1974, Stanford Medicine researcher William S. Robinson successfully isolated the genome of the hepatitis B virus, which is…
In 1974, the Expanded Programme on Immunization was created within World Health Organization (WHO)Â in response to poor…
In 1971, the U.S. Centers for Disease Control and Prevention (CDC) discovered that hepatitis B is sexually transmitted….
In 1971, the testing of donated blood for Hepatitis B surface antigen began. The hepatitis B virus was…
In 1947, after almost 10 years of inquiry into the nature of this illness, F.O. MacCallum, a British…